Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Capital Employed (2021 - 2025)

Biofrontera has reported Return on Capital Employed over the past 5 years, most recently at 112.39% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 9527.0% year-over-year to 112.39%; the TTM value through Dec 2025 reached 112.39%, up 9527.0%, while the annual FY2025 figure was 84.45%, 4798.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 112.39% at Biofrontera, up from 337.12% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 1232.83% in Q2 2025 and troughed at 337.12% in Q3 2025.
  • A 5-year average of 51.48% and a median of 123.19% in 2021 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 137061bps in 2025 and fell as far as -12228bps in 2025.
  • Year by year, Return on Capital Employed stood at 123.19% in 2021, then skyrocketed by 53bps to 57.8% in 2022, then plummeted by -203bps to 175.38% in 2023, then decreased by -18bps to 207.66% in 2024, then skyrocketed by 46bps to 112.39% in 2025.
  • Business Quant data shows Return on Capital Employed for BFRI at 112.39% in Q4 2025, 337.12% in Q3 2025, and 1232.83% in Q2 2025.